The U.S. Office of Pharmacy Affairs (OPA), the department within the U.S Health and Resources Administration that oversees the 340B program, would receive a $2 million increase in funding under a bill that passed through a major House committee last week.
The bill would provide OPA with $13.2 million for the fiscal year that starts Oct. 1, a $2 million increase over this fiscal year’s level. It would be the agency’s first increase in several years. The Biden administration asked for $17 million for OPA in March.
The U.S. Office of Pharmacy Affairs (OPA), the department within the U.S Health and Resources Administration that oversees the 340B program, would receive a $2 million increase in funding under a bill that passed through a major House committee last week.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
